HLA-DQA1*05 ALLELE CARRAIGE AND ANTI-TNF THERAPY PERSISTENCE IN INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Doherty, Jayne
Ryan, Anthony W.
Quinn, Emma
Dolan, Jackie
Corcoran, Roisin
O'Hara, Fintan
Bailey, Yvonne
Mcnamara, Deirdre
Doherty, Glen
Kevans, David
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1796
引用
收藏
页码：S435 / S436
页数：2
相关论文
共 50 条
  • [11] HLA-DQA1*05 allele and its association with the secondary loss of response to infliximab in patients with Inflammatory Bowel Disease
    Angulo Mcgrath, I.
    Brach Gonzalez, M.
    Ocana Ledesma, A.
    Olmedo Martin, R. V.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S326 - S327
  • [12] Impact of the HLA-DQA1*05 Allele on Ustekinumab Loss of Response, Anti-drug Antibodies, and Concentration in Patients With Inflammatory Bowel Disease
    Colombel, Jean-Frederic
    Martin-Arranz, Maria D.
    Brinkman, Brigitta
    Gasink, Christopher
    Guan, Meijian
    Hart, Amy
    Ahmad, Tariq
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S15 - S15
  • [13] HLA-DQA1*05 IS ASSOCIATED WITH HIGHER RATES OF ANTIBODY FORMATION AND LOWER SERUM DRUG LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH ANTI-TNF AGENTS
    Gu, Cihang
    Naseer, Maliha
    Pabla, Baldeep S.
    Dalal, Robin
    Beaulieu, Dawn
    Schwartz, David A.
    Horst, Sara N.
    Scoville, Elizabeth A.
    GASTROENTEROLOGY, 2022, 162 (07) : S809 - S810
  • [14] The association of HLA-DQA1*05 carriage with immunogenicity to anti-tumour necrosis factor therapy and drug persistence in Asian patients with inflammatory bowel disease
    Liang, R.
    Lin, H.
    Goh, L. L.
    Lim, W. C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1635 - I1636
  • [15] HLA-DQA1*05 GENOTYPE AND ANTI-TNF IMMUNOGENICITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Solitano, Virginia
    Facciorusso, Antonio
    Nguyen, Tran M.
    Colman, Ruben J.
    Zou, Lily
    Boland, Brigid S.
    Syversen, Silje W.
    Joergensen, Kristin K.
    Ma, Christopher
    Armuzzi, Alessandro
    Wilson, Aze
    Jairath, Vipul
    Singh, Siddharth
    GASTROENTEROLOGY, 2023, 164 (06) : S439 - S439
  • [16] HLA-DQA1*05 ASSOCIATES WITH IMMUNOGENICITY AND LOSS OF RESPONSE TO ANTI-TNF THERAPY IN THE IBD POPULATION: A META-ANALYSIS
    Bergstein, Suzannah
    Spencer, Elizabeth
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S58 - S58
  • [17] Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease
    Guardiola, J.
    Rodriguez Alonso, L.
    Santacana, E.
    Padro, A.
    Serra, K.
    Padulles, N.
    Ruiz-Cerulla, A.
    Gilabert, P.
    Arajol, C.
    Ibanez-Sanz, G.
    Camps, B.
    Orobitg, J.
    Serracarbasa, A.
    de la Pena, L.
    Berrozpe, A.
    Rodriguez Moranta, F.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S435 - S436
  • [18] HLA-DQA1*05 ASSOCIATES WITH IMMUNOGENICITY AND LOSS OF RESPONSE TO ANTI-TNF THERAPY IN THE IBD POPULATION: A META-ANALYSIS
    Bergstein, Suzannah
    Spencer, Elizabeth
    GASTROENTEROLOGY, 2023, 164 (04) : S74 - S74
  • [19] HLA-DQA1*05 associates with immunogenicity and loss of response to anti-TNF therapy in the IBD population: A meta-analysis
    Bergstein, S.
    Spencer, E. A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I148 - I149
  • [20] Withdrawal of immunomodulatory therapy is feasible in anti-TNF treated patients with negative HLA-DQA1*05-an observational study
    Gonzalez, Haidee Aleman
    Whitehead, Emma
    Pattinson, Alison
    Stamp, Katie
    Turnbul, Jack
    Bautista, Nannet
    Robertson, Hayley
    Sebastian, Shaji
    GUT, 2023, 72 (SUPPL_2) : A102 - A102
12345